Received Jul 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
i got the Shingrix vaccine in 2019 and mistakenly got the vaccine again today (1st shot); This non-serious case was reported by a consumer via interactive digital media and described the occurrence of extra dose administered in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in 2019 on an unknown date). On 14-JUL-2025, the patient received Shingrix. On 14-JUL-2025, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: i got the Shingrix vaccine in 2019 and mistakenly got the vaccine again today (1st shot)). The outcome of the extra dose administered was not applicable. Additional Information: GSK receipt date: 14-JUL-2025 The patient received the Shingrix vaccine in 2019 and mistakenly got the vaccine again on the reporting day (1st shot), which led to extra dose administered.